Polymorphism of Slc11a1 (Nramp1) gene and canine leishmaniasis in a case-control study

Journal of Heredity

Volumn 96, Issue 7, 2005, Pages 755-758

  Sanchez Robert, E ^a   Altet, L ^a   Sanchez, A ^a   Francino, O ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPORTER; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; NUCLEOTIDE; SOLUTE CARRIER FAMILY 11 MEMBER A1; UNCLASSIFIED DRUG;

ARTICLE; BREED; DOG; DOG DISEASE; GENE FREQUENCY; GENERAL ASPECTS OF DISEASE; GENETIC DIFFERENCE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; LEISHMANIASIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; BASE SEQUENCE; CASE-CONTROL STUDIES; CATION TRANSPORT PROTEINS; DISEASE SUSCEPTIBILITY; DOG DISEASES; DOGS; GENOTYPE; HAPLOTYPES; LEISHMANIASIS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS, DNA;

ANIMALIA; CANIS FAMILIARIS;

EID: 28644448938     PISSN: 00221503     EISSN: 14657333     Source Type: Journal    
DOI: 10.1093/jhered/esi111     Document Type: Article

References (23)

1. Altet L, Francino O, Solano-Gallego L, Renier C, and Sanchez A, 2002. Mapping and sequencing of the canine NRAMP1 gene and identification of mutations in leishmaniasis-susceptible dogs. Infect Immun 70:2763-2771.
2. Alvar J, Cañavate C, Gutierrez-Solar B, Jimenez M, Laguna F, Lopez-Velez R, Molina R, and Moreno J, 1997. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev 10:298-319.
3. Blackwell JM, Goswami T, Evans CAW, Sibthorpe D, Papo N, White JK, Searle S, Miller EN, Peacock CS, Mohammed H, and Ibrahim M, 2001. SLC11a1 (formerly NRAMP1) gene and disease resistance. Cell Microbiol 3:773-784.
4. Blackwell JM, Searle S, Mohammed H, and White JK, 2003. Divalent cation transport and susceptibility to infectious and autoimmune disease: continuation of the Ity/Lsh/Bcg/Nramp1/Slc11a1 gene story. Immunol Lett 85:197-203.
5. Enserink M, 2000. Has leishmaniasis become endemic in the U.S.? Science 290:1881-1883.
6. Francino O, Amills M, and Sanchez A, 1997. Canine MHC DRB1 genotyping by PCR-RFLP analysis. Anim Genet 28:41-45.
7. Gaskin AA, Schantz P, Jackson J, Birkenheuer A, Tomlinson L, Gramiccia M, Levy M, Steurer F, Kollmar E, Hegarty BC, Ahn A, and Breitschwerdt EB, 2002. Visceral leishmaniasis in a New York foxhound kennel. J Vet Intern Med 16:34-44.
8. Herwaldt BL, 1999. Leishmaniasis. Lancet 354:1191-1199.
9. Lindsay DS, Zajac AM, and Barr SC, 2002. Canine leishmaniasis in the American Foxhounds: an emerging zoonosis? Comp Cont Ed Pract Vet 24:304-312.
10. Miranda S, Roura X, Alberola J, Ferrer L, and Ramis A, 2005. Clinically patent canine leishmaniasis shows age, breed and sex predilection. In: Worldleish3. Third World Congress on Leishmaniasis. Palermo-Terrassini Sicily, Italy. 10-15 April 2005. Abstract book; 171.
11. Molina R, Amela C, Nieto J, San-Andres H, Gonzalez F, Castillo JA, Lucientes J, and Alvar J, 1994. Infectivity of dogs naturally infected with Leishmania infantum to colonized Phlebotomus perniciosus. Trans R Soc Trop Med Hyg 88:491-493.
12. Moreno J and Alvar J, 2002. Canine leishmaniasis: epidemiological risk and the experimental model. Trends Parasitol 18:399-405.
13. Ouchi K, Suzuki Y, Shirakawa T, and Kishi F, 2003. Polymorphism of the SLC11a1 (formerly NRAMP1) gene confers susceptibility to Kawasaki disease. J Infect Dis 187:326-329.
14. Quinnell RJ, Kennedy LJ, Barnes A, Courtenay O, Dye C, Garcez LM, Shaw MA, Carter SD, Thomson W, and Ollier WE, 2003. Susceptibility to visceral leishmaniasis in the domestic dog is associated with MHC class II polymorphism. Immunogenetics 55:23-28.
15. Searle S and Blackwell JM, 1999. Evidence for a functional repeat polymorphism in the promoter of the human NRAMP1 gene that correlates with autoimmune versus infectious disease susceptibility. J Med Genet 36:295-299.
16. Slappendel RJ, 1988. Canine leishmaniasis: a review based on 95 cases in the Netherlands. Vet Q 10:1-16.
17. Slappendel RJ and Ferrer L, 1998. Leishmaniasis. In: Infectious diseases of a dog and cat (Greene CE, ed). Philadelphia: W. B. Saunders; 450-458.
18. Solano-Gallego L, Llull J, Ramos G, Riera C, Arboix M, Alberola J, and Ferrer L, 2000. The Ibizian hound presents a predominantly cellular immune response against natural Leishmania infection. Vet Parasitol 90:37-45.
19. Solano-Gallego L, Monell P, Arboix M, Alberola J, and Ferrer L, 2001. Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology. J Clin Microbiol 39:560-563.
20. Stephens M, Smith N, and Donnelly P, 2001. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989.
21. Stephens M and Donnelly P, 2003. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162-1169.
22. Vidal SM, Malo D, Vogan K, Skamene E, and Gros P, 1993. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 73:469-485.
23. Zaahl MG, Robson KJ, Warnich L, and Kotze MJ, 2004. Expression of the SLC11A1 (NRAMP1) 5′-(GT)n repeat: opposite effect in the presence of -237C→T. Blood Cells Mol Dis 33:45-50.